Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.69% |
| 2 | Technology | 12.68% |
| 3 | Financials | 12.18% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Acadia Healthcare
ACHC
$3.01B
| $765K | ﹤0.01% |
29,756
-9,283
| -24% | -$321K |
|
2702
CALL
Cooper Companies
COO
$14.1B
| $764K | ﹤0.01% |
12,000
-8,000
| -40% | -$518K |
|
2703
United Bankshares
UBSI
$6.71B
| $764K | ﹤0.01% |
24,565
-68,969
| -74% | -$2.33M |
|
2704
iShares MSCI Qatar ETF
QAT
$64.2M
| $763K | ﹤0.01% |
41,272
-794
| -2% | -$14.8K |
|
2705
Corbus Pharmaceuticals
CRBP
$168M
| $761K | ﹤0.01% |
4,342
+3,336
| +332% | +$666K |
|
|
UCFC
2706
DELISTED
United Community Financial Corp
UCFC
| $761K | ﹤0.01% |
85,996
-34,431
| -29% | -$316K |
|
2707
PUT
Allegion
ALLE
$13.7B
| $757K | ﹤0.01% |
+9,500
| New | +$820K |
|
|
KRA
2708
DELISTED
Kraton Corporation
KRA
| $757K | ﹤0.01% |
34,673
-49,583
| -59% | -$1.45M |
|
|
DCOM
2709
DELISTED
Dime Community Bancshares
DCOM
| $752K | ﹤0.01% |
44,282
+25,285
| +133% | +$430K |
|
2710
Monro
MNRO
$537M
| $749K | ﹤0.01% |
10,901
-6,408
| -37% | -$468K |
|
|
PINC
2711
CALL
DELISTED
Premier
PINC
| $747K | ﹤0.01% |
+20,000
| New | +$827K |
|
|
CMD
2712
CALL
DELISTED
Cantel Medical Corporation
CMD
| $745K | ﹤0.01% |
10,000
-5,000
| -33% | -$413K |
|
2713
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
| $743K | ﹤0.01% |
+9,738
| New | +$815K |
|
2714
Mesa Laboratories
MLAB
$559M
| $743K | ﹤0.01% |
3,566
-26,586
| -88% | -$5.18M |
|
|
MYOV
2715
DELISTED
Myovant Sciences Ltd.
MYOV
| $743K | ﹤0.01% |
45,274
-355,089
| -89% | -$7M |
|
2716
Ducommun
DCO
$2.68B
| $741K | ﹤0.01% |
20,397
+11,398
| +127% | +$439K |
|
2717
MasTec
MTZ
$24.7B
| $738K | ﹤0.01% |
18,200
-401,610
| -96% | -$17.3M |
|
2718
Manulife Financial
MFC
$74.2B
| $737K | ﹤0.01% |
51,953
-165,754
| -76% | -$2.63M |
|
2719
Geron
GERN
$930M
| $736K | ﹤0.01% |
+736,307
| New | +$1.12M |
|
|
JNCE
2720
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $735K | ﹤0.01% |
218,024
-422,237
| -66% | -$1.97M |
|
|
UPL
2721
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $735K | ﹤0.01% |
966,466
+346,450
| +56% | +$438K |
|
|
CBMB
2722
DELISTED
CBM Bancorp, Inc.
CBMB
| $734K | ﹤0.01% |
+58,639
| New | +$734K |
|
|
ALX
2723
Alexander's
ALX
$1.36B
| $732K | ﹤0.01% |
2,401
-4,228
| -64% | -$1.35M |
|
|
OPOF
2724
DELISTED
Old Point Financial
OPOF
| $731K | ﹤0.01% |
33,505
-4,379
| -12% | -$113K |
|
2725
Prothena Corp
PRTA
$448M
| $731K | ﹤0.01% |
70,962
-667,063
| -90% | -$7.93M |
|
Similar funds
Millennium Management's Q4 2018 Portfolio in Review
As of Q4 2018, Millennium Management held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Millennium Management withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Athenahealth, Inc. worth $135M.
- Millennium Management's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Millennium Management added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Millennium Management's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Millennium Management fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Millennium Management's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Millennium Management opened 702 new positions and closed 844 in Q4 2018.
- Millennium Management's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.